Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-07-28 02:01 UTC

BIOMED PULSE

Monday, July 28, 2026

⚡ TL;DR

The Ebola Bundibugyo virus outbreak in DRC and Uganda has now crossed 2,124 confirmed cases and 828 deaths as of July 15, making it the dominant global health emergency of 2026. [1] Alongside Ebola, a WHO-guided dementia prevention update and a new Urolithin A aging trial signal cautious progress on the longevity front. [2][3]

🦠 OUTBREAKS & VIRUSES

EBOLA BUNDIBUGYO VIRUS - DRC AND UGANDA (PHEIC)

  • As of July 15, 2026, WHO confirmed 2,124 cases and 828 deaths from Bundibugyo virus disease (BVD) in DRC, with cross-border transmission ongoing in Uganda. [1]
  • The PARTNERS clinical trial, opened July 2 in DRC, is the first-ever trial enrolling patients to evaluate treatments specifically for Bundibugyo virus disease. [4]
  • WHO added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing on July 2, allowing rapid genetic-material detection in blood samples. [5]
  • WHO issued its first comprehensive filovirus disease clinical management guidelines on June 17, covering all Ebola types and Marburg virus. [6]
  • Africa CDC and WHO launched a joint continental Ebola response plan seeking to raise US$518 million to support African country preparedness. [7]
  • Enhanced Ebola airport screening expanded beyond Washington-Dulles to Atlanta as transmission remained active. [8]
  • The WHO Director-General declared this outbreak a Public Health Emergency of International Concern (PHEIC) but stated it does not meet pandemic emergency criteria. [9]

CYCLOSPORA - UNITED STATES

  • Shredded iceberg lettuce served at Taco Bell locations is confirmed as the source of Cyclospora cayetanensis infections across five states, with 1,644 people reported sick as of July 17. [10]
  • The outbreak has since expanded to four additional states as of July 24.

ANDES HANTAVIRUS - M/V HONDIUS CRUISE SHIP, MULTI-COUNTRY

  • The Andes hantavirus (ANDV) outbreak linked to cruise ship M/V Hondius has been the subject of five WHO Disease Outbreak News reports since May 2, with ongoing multi-country spread among passengers and crew.
  • A CDC transcript update on hantavirus response was issued as recently as June 24, 2026.

NIPAH VIRUS - INDIA

  • On June 11, 2026, Kerala State, India confirmed one laboratory case of Nipah virus infection in an adult male in Kozhikode district, with neurological presentation.
  • Earlier in 2026, Bangladesh reported a confirmed Nipah case in Rajshahi Division in February, with fever and neurological symptoms.

MPOX - RECOMBINANT STRAIN ALERT

  • WHO documented two cases of a recombinant mpox strain combining genomic elements of both clade Ib and clade IIb MPXV, a natural but significant recombination event flagged in February 2026.

AVIAN INFLUENZA A(H9N2) - ITALY

  • Italy notified WHO in March 2026 of a human case of avian influenza A(H9N2) in an adult male returning from Senegal, confirmed by next-generation sequencing.

MEASLES - BANGLADESH

  • Bangladesh reported 19,161 suspected measles cases and 2,897 laboratory-confirmed cases spanning 58 of 64 districts across all eight divisions as of April 2026.

WEST NILE VIRUS - UNITED STATES

  • CDC flagged an early and record-pace West Nile virus season ahead of the July 4 holiday weekend, urging mosquito bite prevention measures nationally.

E. COLI - FROZEN BLUEBERRIES, UNITED STATES

  • CDC issued a food safety alert on July 7, 2026 linking an E. coli outbreak to frozen blueberries, with a product recall in effect.

YELLOW FEVER - GLOBAL

  • From January 1 to May 26, 2026, six countries reported 79 human yellow fever infections, following elevated transmission in the Americas in 2025.

🧬 LONGEVITY & AGING

DEMENTIA PREVENTION - NEW WHO GUIDELINES

  • WHO released updated dementia risk-reduction guidelines on July 15, 2026, concluding that up to 45 percent of dementia risk may be preventable or delayable through evidence-based interventions across the life course. [2]
  • The guidelines provide countries with specific recommendations targeting modifiable risk factors such as cardiovascular health, physical activity, and social engagement. [2]

SENESCENCE AND BONE REPAIR - NAD+ MECHANISM

  • A Europe PMC study published June 27 describes a hierarchical scaffold that modulates senescent cell metabolism, restoring NAD+ homeostasis and redox balance to improve aged bone repair in preclinical models.
  • NAD+ depletion is a well-established hallmark of cellular aging, and restoring it is a central target in geroscience research.

KAEMPFEROL AND LONGEVITY - MORINGA COMPOUND STUDY

  • Research published June 25 in Toxicology Reports found that kaempferol, a flavonoid from Moringa oleifera, increased longevity and reduced efavirenz-induced functional senescence in Drosophila melanogaster models.
  • The irony is notable: moringa leaf products are simultaneously implicated in multiple ongoing U.S. Salmonella outbreaks.

COLLAGEN XVII AND SKIN AGING

  • A study published July 16 in Annals of Medicine found that recombinant human collagen XVII protects epidermal stem cells from blue light-induced photoaging by downregulating the Notch signaling pathway.
  • Epidermal stem cell preservation is considered a key mechanism for maintaining skin barrier integrity with age.

TELOMERE REPAIR AND CANCER AGING BIOLOGY

  • Research published July 23 examined repair and misrepair of telomeric DNA in doxorubicin-treated cancer cells, finding dynamic interactions with PML nuclear bodies and lamin B1.
  • Telomere dysfunction is a primary driver of cellular senescence and genomic instability in aging tissue.

HYPERTENSION AND FRAILTY IN OLDER ADULTS

  • A letter published July 7 in Blood Pressure highlighted associations between hypertension and frailty among middle-aged and older adults using data from the Longitudinal Ageing Study in India.
  • The finding reinforces cardiovascular control as a key pillar of healthy aging strategies.

TAU AND NEURODEGENERATION

  • A July 7 study in Nucleus found that the mechanically-sensitive protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons, potentially a new pathway in Alzheimer's and tauopathy research.

CANCER BURDEN PROJECTIONS - WHO

  • WHO projected on July 8 that new cancer cases will nearly double by 2050, with current annual figures at 20.6 million new cases and approximately 10 million deaths, or more than 26,000 deaths per day globally.

💊 NEW CURES & APPROVALS

GENERIC AND SUPPLEMENTAL APPROVALS FROM openFDA

  • MSN Pharmaceuticals received an original ANDA approval for generic Carfilzomib, a proteasome inhibitor used in multiple myeloma (previously branded as Kyprolis by Amgen).
  • Teva Pharmaceuticals USA received an original tentative approval for generic Canagliflozin, an SGLT2 inhibitor used in type 2 diabetes and heart failure.
  • Teva Pharmaceuticals Inc received an original ANDA approval for generic Tolvaptan, a vasopressin receptor antagonist used in autosomal dominant polycystic kidney disease and hyponatremia.
  • Novitium Pharma received an original ANDA approval for generic Pitolisant Hydrochloride, an H3 receptor inverse agonist used to treat narcolepsy.
  • Accord received a supplemental approval for CAMCEVI ETM (leuprolide mesylate), a GnRH agonist from NDA 219745, used in hormone-sensitive prostate cancer.
  • Bristol Myers Squibb received a supplemental approval for REVLIMID (lenalidomide), used in multiple myeloma and myelodysplastic syndromes, under NDA 021880.
  • Bristol-Myers received a supplemental approval for INREBIC (fedratinib hydrochloride), a JAK2 inhibitor for myelofibrosis, under NDA 212327.
  • Aurobindo Pharma received an original ANDA approval for generic Bupropion Hydrochloride, an antidepressant and smoking cessation aid.
  • Aurobindo Pharma also received an original ANDA approval for generic Adapalene and Benzoyl Peroxide combination, used in acne vulgaris.

🧪 CLINICAL TRIALS

UROLITHIN A FOR GLUCOSE METABOLISM IN AGING - NCT06274749

  • A randomized, triple-masked, controlled trial (NCT06274749) is evaluating Urolithin A (UA) supplementation for improving glucose metabolism and reducing diabetes risk in healthy adults aged 55 and older. [3]
  • Urolithin A is a gut microbiome-derived compound that activates mitophagy, the cellular process of clearing damaged mitochondria, a pathway directly linked to aging biology. [3]

SIROLIMUS (RAPAMYCIN) IN ASYMPTOMATIC APOE4 CARRIERS - NCT07728175

  • A trial registered July 27, 2026 (NCT07728175) is studying the effects of sirolimus, an FDA-approved mTOR inhibitor, in asymptomatic individuals carrying the ApoE4 allele, the strongest genetic risk factor for Alzheimer's disease.
  • Sirolimus has shown lifespan extension in multiple animal models; this trial examines whether it can modulate blood-brain barrier or amyloid pathology in at-risk humans.

EARLY-ONSET ALZHEIMER'S DISEASE - DISEASE MODIFYING TREATMENTS - NCT05552157

  • Trial NCT05552157 is evaluating investigational disease-modifying drugs in participants with confirmed AD-causing genetic mutations, with Stage 1 focused on whether treatment prevents or slows amyloid beta accumulation.
  • The study targets the pre-symptomatic window, a key strategy in the geroscience field to intervene before irreversible neurodegeneration.

📢 PUBLIC HEALTH

CHILDHOOD IMMUNIZATION COVERAGE - WHO/UNICEF 2025 DATA

  • In 2025, 90 percent of infants globally (nearly 116 million) received at least one DTP dose, while 85 percent (110 million) completed the full three-dose series, per the annual WHO-UNICEF WUENIC release.
  • Coverage gains remain fragile due to conflict, vaccine hesitancy, and supply disruptions in several regions.

CDC TRAVELER-BASED GENOMIC SURVEILLANCE MILESTONE

  • CDC's Traveler-Based Genomic Surveillance program surpassed one million voluntary air travel participants on January 30, 2026, strengthening the agency's ability to detect emerging pathogens at borders.

DRUG-RESISTANT BACTERIA ALERT

  • A CDC report published September 23, 2025 found a dramatic increase in a dangerous category of drug-resistant bacteria, underscoring ongoing antimicrobial resistance (AMR) threats in health care settings.

LISTERIA ONGOING - PREPARED MEALS

  • CDC continues to urge consumers to check refrigerators and freezers for recalled prepared meal products linked to a Listeria monocytogenes outbreak; illnesses continued even after recalls.

UNSAFE FOOD - GLOBAL BURDEN UPDATE

  • WHO estimated on June 4, 2026 that unsafe food causes 866 million illnesses and 1.5 million deaths annually worldwide, with children under five facing nearly three times the illness risk of older populations.

U.S. WITHDRAWAL FROM WHO

  • The United States formally completed its WHO withdrawal on January 22, 2026, citing COVID-19 failures and politicization, shifting to bilateral health diplomacy.

This briefing is for informational purposes only and does not constitute medical advice. Always consult a licensed health care professional for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. New WHO guidelines: up to 45% of dementia risk could be preven… — WHO News
  3. Effects of Urolithin A Supplementation on Glucose Metabolism i… — ClinicalTrials.gov — Aging
  4. Patient enrolment begins in a scientific trial to identify the… — WHO News
  5. WHO adds first diagnostic test for Ebola Bundibugyo virus to i… — WHO News
  6. WHO issues comprehensive guidelines on filovirus disease, incl… — WHO News
  7. Africa CDC and WHO launch joint continental Ebola response plan — WHO News
  8. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  9. First meeting of the IHR Emergency Committee regarding the epi… — WHO News
  10. Shredded iceberg lettuce served at Taco Bell locations is sour… — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260728-02-v41 · 2026-07-28 02:01 UTC · pulse.uzylab.com

Read next